ERBB oncogene proteins as targets for monoclonal antibodies

O. L. Polanovski, E. N. Lebedenko, S. M. Deyev

Результат исследований: Материалы для журналаОбзорная статья

35 Цитирования (Scopus)

Аннотация

General properties of the family of tyrosine kinase ERBB receptors are considered in connection with their role in the generation of cascades of signal transduction in normal and tumor cells. Causes of acquisition of oncogene features by genes encoding these receptors and their role in tumorigenesis are analyzed. Anti-ERBB monoclonal antibodies approved for therapy are described in detail, and mechanisms of their antitumor activity and development of resistance to them are reviewed. The existing and the most promising strategies for creating and using monoclonal antibodies and their derivatives for therapy of cancer are discussed.

Язык оригиналаАнглийский
Страницы (с-по)227-245
Число страниц19
ЖурналBiochemistry (Moscow)
Том77
Номер выпуска3
DOI
СостояниеОпубликовано - мар 2012
Опубликовано для внешнего пользованияДа

ASJC Scopus subject areas

  • Biochemistry
  • Medicine(all)

Fingerprint Подробные сведения о темах исследования «ERBB oncogene proteins as targets for monoclonal antibodies». Вместе они формируют уникальный семантический отпечаток (fingerprint).

  • Цитировать